Atlas market file · Equity · United States
Orangekloud Technology Inc.ORKT
- Last close
- 1
- Change
- -1.96%
- 96-bar range
- 0.843 – 1.61
- As of
- 6 Aug 2026
Orangekloud Technology Inc. is a services-prepackaged software issuer listed as ORKT on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-94.99% over the window).
Source rail: Yahoo Finance chart API (ORKT). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for ORKT. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
ORKT public profile
Services-prepackaged software issuer. Orangekloud Technology Inc. is connected to current market context, cited company sources and its retained research file.
Orangekloud Technology Inc. trades as ORKT on NASDAQ. Orangekloud Technology Inc. (ORKT) has a latest verified close of 1, down 1.96%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files ORKT under USA Stocks and Technology Stocks for browsing.
What changed for Orangekloud Technology Inc. today
OrangeKloud Technology Inc. is a Singapore-based outfit selling the eMOBIQ® no-code mobile-app builder to SMEs and corporate clients, and the latest audited accounts for the year ended 31 December 2025 show a company that is still chasing scale rather than profitability. Revenue in the 20-F clocks in at $4.4 million, net loss at $3.5 million, and diluted EPS at minus $0.60 on 5.8 million shares outstanding. The balance sheet lists $9.2 million of assets, $2.6 million of liabilities, and $2.3 million of cash, while operating cash flow is a negative $3.6 million. In short, the group is still funding operations from equity rather than from customers. (source: OrangeKloud Technology Inc. 20-F, period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1979407/000149315226028045/riks-2025-12-31.htm)
The company’s marquee product is the eMOBIQ® no-code platform, which promises to let non-developers drag-and-drop mobile applications in minutes. Orangekloud’s own product pages trumpet Acumatica ISV solutions and cross-platform frameworks like Cordova and React Native, while the newsroom crows about the July 25 launch of eMOBIQ® AI and a strategic tie-up with Intellsync to drive SME digital transformation. The visuals are sleek, the language is futuristic, and the filing reality is $4.4 million of revenue. (source: Acumatica ISV solutions, https://orangekloud.com/acumatica-isv-solutions/; Platform product page, https://orangekloud.com/; News & Events, https://orangekloud.com/news-events/)
On the capital side, OrangeKloud’s S-8 registration statement filed 16 July 2026 allows the sale of up to 1.5 million additional shares. The document does not promise a timetable, a price, or a use of proceeds, but the existing diluted share count is already 5.8 million and the annual revenue base is only $4.4 million. If the goal is to fund growth through equity issuance, the arithmetic is straightforward: each new share must generate more than $2.93 of revenue just to keep revenue-per-share flat. (source: ORKT S-8 POS, https://www.sec.gov/Archives/edgar/data/1979407/000149315226033462/forms-8pos.htm)
The board also disclosed on 16 July 2026 that it has entered a reverse merger agreement with VEVE, but the accompanying 6-K/A immediately reminds readers that any forward-looking statements ‘speak only as of the date hereof’ and that OrangeKloud ‘specifically disclaims any obligation to update’ them. The same filing shows equity of $6.6 million versus liabilities of $2.6 million and operating cash burn of $3.6 million for the year. In other words, the company is still selling a vision while the ledger records a deficit. (source: ORKT 6-K/A, https://www.sec.gov/Archives/edgar/data/1979407/000149315226033427/form6-ka.htm)
What the filings do not yet provide is any segment-level breakdown of where the $4.4 million of revenue is earned, how much is recurring SaaS versus one-off services, or what the customer concentration looks like. OrangeKloud’s own site invites visitors to ‘Start a Free Trial’ and ‘Request a Demo’, but the 20-F gives no insight into trial-to-paid conversion or customer acquisition cost. Until the company files a revenue bridge or a cohort analysis, the source requires readers to take the top-line figure at face value and treat the rest as directional. (source: START A FREE TRIAL, https://orangekloud.com/request-a-demo/)
The free-trial page also carries a product image of the OrangeKloud logo and the tagline ‘OrangeKloud Pte Ltd’, reinforcing that the issuer behind ORKT is a Singapore private limited company rather than a public entity with a US listing. The EDGAR index confirms that all filings are lodged under CIK 1979407, and the companyfacts JSON shows standard XBRL tags for revenue and loss, but the data set stops short of segment detail or geographical split. (source: ORKT SEC EDGAR filing index, https://www.sec.gov/edgar/browse/?CIK=1979407; ORKT companyfacts JSON, https://data.sec.gov/api/xbrl/companyfacts/CIK0001979407.json)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
ORKT technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on ORKT
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep ORKT research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
ORKT FAQ
What is Orangekloud Technology Inc. (ORKT)?Orangekloud Technology Inc. (ORKT) has a latest verified close of 1, down 1.96%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Orangekloud Technology Inc. (ORKT) has a latest verified close of 1, down 1.96%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for ORKT?Orangekloud Technology Inc. (ORKT) has a latest verified close of 1, down 1.96%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources,...
Orangekloud Technology Inc. (ORKT) has a latest verified close of 1, down 1.96%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files ORKT under USA Stocks and Technology Stocks for browsing.
How often is the ORKT page updated?The ORKT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The ORKT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for ORKT?The ORKT file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:ORKT. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The ORKT file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:ORKT. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on ORKT?Yes. The workstation can open ORKT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open ORKT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this ORKT page investment advice?No. The ORKT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The ORKT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
ORKT
Equity · evidence first